Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study

Patrick Rossignol, John G F Cleland, Sunil Bhandari, Stéphane Tala, Finn Gustafsson, Renaud Fay, Zohra Lamiral, Daniela Dobre, Bertram Pitt, Faiez Zannad

    142 Citationer (Scopus)

    Abstract

    We evaluated the effect of the selective mineralocorticoid receptor antagonist eplerenone on renal function and the interaction between changes in renal function and subsequent cardiovascular outcomes in patients with heart failure and left ventricular systolic dysfunction after an acute myocardial infarction in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).
    OriginalsprogEngelsk
    TidsskriftCirculation (Baltimore)
    Vol/bind125
    Udgave nummer2
    Sider (fra-til)271-9
    Antal sider9
    ISSN0009-7322
    DOI
    StatusUdgivet - 2012

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study'. Sammen danner de et unikt fingeraftryk.

    Citationsformater